Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stoppa-Lyonnet

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Annales D'Endocrinologie|April 6, 1999
[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer]F Eisinger, N Alby, A Bremond, et al.
Annales De Genetique|April 24, 1999
[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer]F Eisinger, N Alby, A Bremond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc CommitteeF Eisinger, N Alby, A Bremond, et al.
Bulletin Du Cancer|April 22, 1999
[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary]F Eisinger, N Alby, A Bremond, et al.
Disease Markers|December 14, 1999
Insurance implications for individuals with a high risk of breast and ovarian cancer in EuropeP J Morrison, C M Steel, H F Vasen, et al.
Gene|August 5, 2006
Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIPM Di Benedetto, I Bièche, F Deshayes, et al.
Oncogene|September 13, 2003
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphomaR M'kacher, A Bennaceur, F Farace, et al.
Neuromolecular Medicine|January 17, 2013
Molecular defects in Moroccan patients with ataxia-telangiectasiaL Jeddane, F Ailal, C Dubois-d'Enghien, et al.
American Journal of Human Genetics|May 1, 1997
BRCA2 mutations in hereditary breast and ovarian cancer in FranceO M Serova-Sinilnikova, L Boutrand, D Stoppa-Lyonnet, et al.
Pediatric Blood & Cancer|August 24, 2013
Malformations, genetic abnormalities, and Wilms tumorS Dumoucel, M Gauthier-Villars, D Stoppa-Lyonnet, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Annales D'Endocrinologie|April 6, 1999
[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer]F Eisinger, N Alby, A Bremond, et al.
Annales De Genetique|April 24, 1999
[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer]F Eisinger, N Alby, A Bremond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc CommitteeF Eisinger, N Alby, A Bremond, et al.
Bulletin Du Cancer|April 22, 1999
[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary]F Eisinger, N Alby, A Bremond, et al.
Disease Markers|December 14, 1999
Insurance implications for individuals with a high risk of breast and ovarian cancer in EuropeP J Morrison, C M Steel, H F Vasen, et al.
Gene|August 5, 2006
Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIPM Di Benedetto, I Bièche, F Deshayes, et al.
Oncogene|September 13, 2003
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphomaR M'kacher, A Bennaceur, F Farace, et al.
Neuromolecular Medicine|January 17, 2013
Molecular defects in Moroccan patients with ataxia-telangiectasiaL Jeddane, F Ailal, C Dubois-d'Enghien, et al.
American Journal of Human Genetics|May 1, 1997
BRCA2 mutations in hereditary breast and ovarian cancer in FranceO M Serova-Sinilnikova, L Boutrand, D Stoppa-Lyonnet, et al.
Pediatric Blood & Cancer|August 24, 2013
Malformations, genetic abnormalities, and Wilms tumorS Dumoucel, M Gauthier-Villars, D Stoppa-Lyonnet, et al.
Pageof 13